Christine Granfield

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Granfield:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Common Stock 15,896 $5,033 $0.3166 28 Mar 2025 Direct
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Restricted Stock Units 0 $0 $0.3166 28 Mar 2025 Direct
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Employee Stock Option (Right to Buy) 85,000 02 Oct 2024 Direct

Insider Reports Filed by Christine Granfield

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LPTX LEAP THERAPEUTICS, INC. 28 Mar 2025 3 -$2,091 4 VP, Head of Reg Affairs/Qual 01 Apr 2025, 21:54
LPTX LEAP THERAPEUTICS, INC. 02 Oct 2024 1 $0 4 VP, Head of Reg Affairs/Qual 04 Oct 2024, 17:29
LPTX LEAP THERAPEUTICS, INC. 29 Jan 2024 1 $0 4 VP, Head of Reg Affairs/Qual 31 Jan 2024, 21:35
LPTX LEAP THERAPEUTICS, INC. 23 Aug 2023 1 $0 4 VP, Head of Reg Affairs/Qual 25 Aug 2023, 16:30
LPTX LEAP THERAPEUTICS, INC. 31 Mar 2023 1 $0 4 VP, Head of Reg Affairs/Qual 04 Apr 2023, 20:15
LPTX LEAP THERAPEUTICS, INC. 01 Sep 2022 1 $0 4 VP, Head of Reg Affairs/Qual 02 Sep 2022, 21:29
LPTX LEAP THERAPEUTICS, INC. 31 Jan 2022 1 $0 4 VP, Head of Reg Affairs/Qual 02 Feb 2022, 20:46
LPTX LEAP THERAPEUTICS, INC. 26 May 2021 1 $0 4 VP, Head of Reg Affairs/Qual 28 May 2021, 20:36